QL
APLS

Quarry LP’s Apellis Pharmaceuticals APLS Stock Holding History

Quarry LP’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,000
Closed -$126K – 1425
2025
Q4 		$126K Sell
5,000
-11,022
-69% -$259K 0.02% 364
2025
Q3 		$363K Buy
16,022
+11,022
+220% +$257K 0.08% 228
2025
Q2 		$86.5K Buy
+5,000
New +$92.6K 0.02% 615
2024
Q2 		– Sell
-3,000
Closed -$176K – 1786
2024
Q1 		$176K Buy
+3,000
New +$191K 0.03% 191
2023
Q4 		– Sell
-3,500
Closed -$133K – 1377
2023
Q3 		$133K Buy
+3,500
New +$154K 0.03% 174

Other funds holding APLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Quarry LP's APLS Position: Q1 2026 in Review

Quarry LP sold out of Apellis Pharmaceuticals (APLS) in Q1 2026, closing a stake of 5,000 shares — an estimated $126K sold.

Quarry LP first reported a position in APLS in Q3 2023 and held it in 5 quarters. The position peaked at $363K in Q3 2025. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • Quarry LP reported no remaining Apellis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Quarry LP sold 5,000 Apellis Pharmaceuticals shares in Q1 2026, an estimated $126K.
  • Quarry LP first reported a position in Apellis Pharmaceuticals in Q3 2023 and held it in 5 quarters.
  • Quarry LP's Apellis Pharmaceuticals position peaked at $363K in Q3 2025.
  • 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.